Related references
Note: Only part of the references are listed.Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency
Linlin Yang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
Role of genetic testing in cardiomyopathies: A primer for cardiologists
Georgia Vogiatzi et al.
WORLD JOURNAL OF CARDIOLOGY (2022)
Emerging Genotype-Phenotype Associations in Dilated Cardiomyopathy
Joyce N. Njoroge et al.
CURRENT CARDIOLOGY REPORTS (2022)
Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency
Linlin Yang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)
Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of the literature
Thais Gagno Grillo et al.
World Journal of Clinical Cases (2021)
Hematopoietic Cell Transplantation Rescues Inflammatory Bowel Disease and Dysbiosis of Gut Microbiota in XIAP Deficiency
Shintaro Ono et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Evolution of Our Understanding of XIAP Deficiency
Anne C. A. Mudde et al.
FRONTIERS IN PEDIATRICS (2021)
The Key to a Boy's Heart Is Through His Intestine
Amir Jazayeri et al.
GASTROENTEROLOGY (2020)
X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic
Tao Xu et al.
EUROPEAN JOURNAL OF PEDIATRICS (2020)
LncRNA KCNQ1OT1 attenuates sepsis-induced myocardial injury via regulating miR-192-5p/XIAP axis
Fangyuan Sun et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2020)
X-linked inhibitor of apoptosis protein deficiency complicated with Crohn's disease-like enterocolitis and Takayasu arteritis: A case report
Ichiro Takeuchi et al.
CLINICAL IMMUNOLOGY (2020)
De novo Anti-TNF-α-induced Congestive Heart Failure in a Patient With Turner Syndrome and Crohn's Disease
Eoin Keating et al.
INFLAMMATORY BOWEL DISEASES (2020)
Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report
Ru-Yue Chen et al.
BMC PEDIATRICS (2020)
Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes
Oriol Iborra-Egea et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
Thiamine and Cardiovascular Disease: A Literature Review
James J. DiNicolantonio et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2018)
Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature
Ying-Ying Jin et al.
HUMAN IMMUNOLOGY (2016)
Wernicke's encephalopathy after total parenteral nutrition in patients with Crohn's disease
In Seub Shin et al.
INTESTINAL RESEARCH (2016)
X-linked Inhibitor of Apoptosis Protein Deficiency: More than an X-linked Lymphoproliferative Syndrome
Claire Aguilar et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2015)
XIAP deficiency syndrome in humans
Sylvain Latour et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
High-Output Heart Failure Caused by Thyrotoxicosis and Beriberi
Brenda McCulloch
CRITICAL CARE NURSING CLINICS OF NORTH AMERICA (2015)
Thiamin Function, Metabolism, Uptake, and Transport
Sergio Manzetti et al.
BIOCHEMISTRY (2014)
Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers
Claire Aguilar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
X-linked inhibitor of apoptosis (XIAP) deficiency: The spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis
C. Speckmann et al.
CLINICAL IMMUNOLOGY (2013)
Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling
Rune Busk Damgaard et al.
EMBO MOLECULAR MEDICINE (2013)
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues
Fabio Cacciapaglia et al.
AUTOIMMUNITY REVIEWS (2011)
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)
Jana Pachlopnik Schmid et al.
BLOOD (2011)
Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease
Elizabeth A. Worthey et al.
GENETICS IN MEDICINE (2011)
X-linked lymphoproliferative syndromes: brothers or distant cousins?
Alexandra H. Filipovich et al.
BLOOD (2010)
XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease
Rebecca A. Marsh et al.
BLOOD (2010)
Concurrent upregulation of endogenous proapoptotic and antiapoptotic factors in failing human hearts
Nezam Haider et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2009)
Anti-tumour necrosis factor-α therapy in heart failure:: Future directions
Pitchai Balakumar et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome
Stephaine Rigaud et al.
NATURE (2006)
Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in failing human myocardium - Fragile balance of myocyte survival?
RJ Scheubel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Share Paper
